AusBiotech has announced the re-appointment of Ms Julie Phillips, CEO and executive director of BioDiem, and the re-election of Dr Andrea Douglas, vice president, R&D Strategy and External Affairs, CSL.
Serving as AusBiotech’s Chairman since 2014, and working in the biotechnology for more than 15 years, Ms Phillips has been a passionate and vocal advocate for the biotechnology industry.
Her experience spans large pharmaceutical companies, regulatory affairs, clinical trials, pharmacoeconomics and start-ups. Ms Phillips is also a Director on the Board of the Medical Technologies and Pharmaceuticals Growth Centre (MTPConnect).
Ms Phillips said: “I am honoured to be re-appointed to the Board and as Chairman. The staff team and numerous committees of AusBiotech play an instrumental role in strengthening and nurturing the biotechnology and medical technology industries, and I welcome the opportunity to continue my role in guiding this valued organisation."
Dr Douglas has held various roles at CSL since 2005 and currently oversees the global R&D strategy, product portfolio and R&D investment and prioritisation processes. She is responsible for relationships with external stakeholders in the Australian medical and translational research environment. Dr Douglas also leads the government affairs strategy in Australia.
The AGM was the first for CEO Glenn Cross, who took the helm of AusBiotech after former CEO Dr Anna Lavelle stepped down in September 2016.
“I look forward to working with the Board to continue the work Anna and I have been undertaking during the past decade, and to build upon this work to grow a sustainable Australian biotechnology sector,” he said.
The current Board members include:
Ms Julie Phillips, AusBiotech Chairman and CEO and Executive Director, BioDiem;
Mr Glenn Cross, CEO, AusBiotech;
Ms Michelle Burke, Director, External Affairs, Bristol-Myers Squibb;
Mr Lawrence Gozlan, Chief Executive Officer, Scientia Capital;
Dr Andrea Douglas, Vice President, R&D Strategy and External Affairs, CSL Limited;
Ms Serina Cucuzza, Manager, Commercial Development & Industry Engagement, Burnet Institute;
Mr Barry Thomas, Director, Cook Medical Asia Pacific & Vice President, Cook Medical; and,
Mr Serg Duchini, Partner, Chief Strategy Officer, National Leader R&D and Government Incentives & Co. Director, Deloitte Touche Tohmatsu.